| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000001553 |
| Receipt No. | R000001876 |
| Official scientific title of the study | ECG changes associated with intra-operative tachycardia in patients undergoing a cesarean section and the effect of a short-acting beta blocker. |
| Date of disclosure of the study information | 2011/04/01 |
| Last modified on | 2018/11/21 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | ECG changes associated with intra-operative tachycardia in patients undergoing a cesarean section and the effect of a short-acting beta blocker. | |
| Title of the study (Brief title) | The effect of a beta-blocker on tachycardia that develops during cesarean section. | |
| Region |
|
|
| Condition | ||
| Condition | patients undergoing a cesarean section | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | ST depression occurs in association with tachycardia in some patients undergoing a cesarean section;but the pathological significance or the frequency of this deveolpment is not known.The patients were divided into two groups for the present study, which was conducted to elucidate the significance and frequency of this ST depression, as well as the effect of a short-acting beta-blocker for such a condition. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Verify whether or not ECG changes can be supressed by preventing an increase in heart rate. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | For those patients whose their heart rates exceeding 100, continuous infusion of a short-acting beta-blocker was started to maintain their heart rate below 90. | |
| Interventions/Control_2 | For those patients develops ECG change at a heart rate below 100,sustained infusion of a beta blocker was started so that their heart rate associated with ECG change may be kept below 90% of that when changes had occurred. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | The participants of this study are those patients who submitted a written informed consent after sufficient information had been given. | |||
| Key exclusion criteria | Patients who have a history of hypersensitivity to short-acting beta-blockers. | |||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Aya Nakae |
| Organization | Osaka University Graduate School of Medicine |
| Division name | Department of Anestheiology and Intensive Care |
| Address | 2-2 Yamadaoka Suita |
| TEL | |
| Public contact | |
| Name of contact person | |
| Organization | Osaka University Graduate School of Medicine |
| Division name | Department of Anestheiology and Intensive Care |
| Address | 2-2 Yamadaoka Suita |
| TEL | |
| Homepage URL | |
| Sponsor | |
| Institute | Osaka University Graduate School of Medicine
Department of Anestheiology and Intensive Care |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001876 |